miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ

C Quintavalle1, M Garofalo, C Zanca

  • 1Department of Cellular and Molecular Biology and Pathology, Federico II University of Naples, Naples, Italy.

Oncogene
|July 12, 2011
PubMed

Insights

MicroRNAs miR-221 and miR-222 promote glioma growth by downregulating PTPμ. Restoring PTPμ expression reverses these effects, suggesting a therapeutic target for glioblastoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma is a highly lethal adult brain cancer with poor patient survival.
  • MicroRNAs (miRs) are implicated in cancer development, but their specific roles in glioblastoma are not fully understood.

Purpose of the Study:

  • To identify microRNAs involved in glioma tumorigenesis.
  • To investigate the role of miR-221 and miR-222 in regulating glioblastoma cell behavior through their target, PTPμ.

Main Methods:

  • Differential microRNA expression profiling using miRarray in glioma and non-tumorigenic cells.
  • Validation of miR-221 and miR-222 targets using Western blot and real-time PCR.
  • Assessment of cell migration and growth in soft agar assays.
  • Analysis of miR-221, miR-222, and PTPμ expression in human glioma samples.

Main Results:

  • miR-221 and miR-222 were found to be differentially expressed in glioma cells.
  • Overexpression of miR-221 and miR-222 led to decreased PTPμ expression.
  • miR-221 and miR-222 promoted glioma cell migration and growth.
  • Re-expression of PTPμ reversed the pro-tumorigenic effects of miR-221 and miR-222.
  • An inverse correlation was observed between miR-221/miR-222 and PTPμ in human glioma tissues.

Conclusions:

  • miR-221 and miR-222 are key regulators of glioma tumorigenesis.
  • These miRs exert their effects, at least in part, by controlling PTPμ expression.
  • Targeting miR-221/miR-222 or PTPμ may offer a therapeutic strategy for glioblastoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...